share_log
Benzinga ·  04/25 11:29

CureVac Shares Are Trading Lower After Leerink Partners Downgraded the Stock From Outperform to Market Perform and Lowered Its Price Target From $12 to $4

在Leerink Partners将该股的评级从跑赢大盘下调至市场表现并将其目标股价从12美元下调至4美元之后,CureVac股价走低

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发